Du M, Chen S, Chen Y, Yuan X, Dong H
Anim Biosci. 2023; 37(1):50-60.
PMID: 37641828
PMC: 10766465.
DOI: 10.5713/ab.23.0175.
Yam C, Lim H, Surana U
Front Cell Dev Biol. 2022; 10:1020643.
PMID: 36274841
PMC: 9582513.
DOI: 10.3389/fcell.2022.1020643.
Zheng P, Kang Y, Han S, Feng H, Ha F, Long C
Front Genet. 2021; 11:597803.
PMID: 33519900
PMC: 7838612.
DOI: 10.3389/fgene.2020.597803.
Lafranchi L, Mullers E, Rutishauser D, Lindqvist A
Cells. 2020; 9(9).
PMID: 32961751
PMC: 7564076.
DOI: 10.3390/cells9092126.
Lemmens B, Lindqvist A
J Cell Biol. 2019; 218(12):3892-3902.
PMID: 31712253
PMC: 6891093.
DOI: 10.1083/jcb.201909032.
WIP1 Contributes to the Adaptation of Fanconi Anemia Cells to DNA Damage as Determined by the Regulatory Network of the Fanconi Anemia and Checkpoint Recovery Pathways.
Rodriguez A, Naveja J, Torres L, Garcia de Teresa B, Juarez-Figueroa U, Ayala-Zambrano C
Front Genet. 2019; 10:411.
PMID: 31130988
PMC: 6509935.
DOI: 10.3389/fgene.2019.00411.
DNA Damage Stress: Cui Prodest?.
Verma N, Franchitto M, Zonfrilli A, Cialfi S, Palermo R, Talora C
Int J Mol Sci. 2019; 20(5).
PMID: 30832234
PMC: 6429504.
DOI: 10.3390/ijms20051073.
Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization.
Werwein E, Cibis H, Hess D, Klempnauer K
Nucleic Acids Res. 2018; 47(1):103-121.
PMID: 30321399
PMC: 6326806.
DOI: 10.1093/nar/gky935.
Topokaryotyping demonstrates single cell variability and stress dependent variations in nuclear envelope associated domains.
Jurisic A, Robin C, Tarlykov P, Siggens L, Schoell B, Jauch A
Nucleic Acids Res. 2018; 46(22):e135.
PMID: 30215776
PMC: 6294560.
DOI: 10.1093/nar/gky818.
CDK1 and PLK1 coordinate the disassembly and reassembly of the nuclear envelope in vertebrate mitosis.
de Castro I, Sales Gil R, Ligammari L, Di Giacinto M, Vagnarelli P
Oncotarget. 2018; 9(8):7763-7773.
PMID: 29487689
PMC: 5814256.
DOI: 10.18632/oncotarget.23666.
The CDK-PLK1 axis targets the DNA damage checkpoint sensor protein RAD9 to promote cell proliferation and tolerance to genotoxic stress.
Wakida T, Ikura M, Kuriya K, Ito S, Shiroiwa Y, Habu T
Elife. 2017; 6.
PMID: 29254517
PMC: 5736350.
DOI: 10.7554/eLife.29953.
ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.
Jaiswal H, Benada J, Mullers E, Akopyan K, Burdova K, Koolmeister T
EMBO J. 2017; 36(14):2161-2176.
PMID: 28607002
PMC: 5510006.
DOI: 10.15252/embj.201696082.
Analysis of global DNA methylation changes in primary human fibroblasts in the early phase following X-ray irradiation.
Maierhofer A, Flunkert J, Dittrich M, Muller T, Schindler D, Nanda I
PLoS One. 2017; 12(5):e0177442.
PMID: 28489894
PMC: 5425224.
DOI: 10.1371/journal.pone.0177442.
The G2 checkpoint-a node-based molecular switch.
de Gooijer M, van den Top A, Bockaj I, Beijnen J, Wurdinger T, van Tellingen O
FEBS Open Bio. 2017; 7(4):439-455.
PMID: 28396830
PMC: 5377395.
DOI: 10.1002/2211-5463.12206.
Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.
Xu L, Zhu Y, Shao J, Chen M, Yan H, Li G
Br J Cancer. 2017; 116(8):1027-1036.
PMID: 28267710
PMC: 5396112.
DOI: 10.1038/bjc.2017.55.
Early S-phase cell hypersensitivity to heat stress.
Petrova N, Velichko A, Razin S, Kantidze O
Cell Cycle. 2015; 15(3):337-44.
PMID: 26689112
PMC: 4943689.
DOI: 10.1080/15384101.2015.1127477.
Mitotic entry: Non-genetic heterogeneity exposes the requirement for Plk1.
Aspinall C, Zheleva D, Tighe A, Taylor S
Oncotarget. 2015; 6(34):36472-88.
PMID: 26472023
PMC: 4742190.
DOI: 10.18632/oncotarget.5507.
Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process.
Rodriguez A, Torres L, Juarez U, Sosa D, Azpeitia E, Teresa B
Theor Biol Med Model. 2015; 12:19.
PMID: 26385365
PMC: 4575447.
DOI: 10.1186/s12976-015-0011-4.
PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
Zuco V, De Cesare M, Zaffaroni N, Lanzi C, Cassinelli G
Oncotarget. 2015; 6(11):8736-49.
PMID: 25826089
PMC: 4496180.
DOI: 10.18632/oncotarget.3538.
The cancer genome: from structure to function.
Geurts van Kessel A
Cell Oncol (Dordr). 2014; 37(3):155-65.
PMID: 24980027
DOI: 10.1007/s13402-014-0177-5.